ClinicalTrials.Veeva

Menu

MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry (German MYVAL S)

P

Prof. Dr. med. Ingo Eitel

Status

Enrolling

Conditions

Aortic Valve Stenosis

Treatments

Device: Myval Transcatheter Heart Valve

Study type

Observational

Funder types

Other

Identifiers

NCT06804148
2024-500

Details and patient eligibility

About

Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient is going to be treated with Myval THV
  • Age ≥ 18 years
  • Ability to give informed consent

Exclusion criteria

  • Pregnant and lactating women
  • Patients with hyper sensitivity or allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum or any contrast media.
  • Patients in whom anti-platelet and/or anticoagulant therapy are contra-indicated.
  • Any condition, which in the Investigator's opinion, would preclude safe participation of patient in the registry

Trial contacts and locations

1

Loading...

Central trial contact

Christian Frerker, PD Dr.; Ingo Eitel, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems